Extensively drug-resistant tuberculosis; (XDR TB)
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
i


Extensively drug-resistant tuberculosis; (XDR TB)
Filetype[PDF-326.24 KB]


Details:
  • Supporting Files:
    No Additional Files
No Related Documents.

You May Also Like:

  1. Corporate Authors:
    National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (U.S.), Division of Tuberculosis Elimination.
    Published Date:
    November 2011
    Series:
    TB elimination
    Description:
    "Untreated tuberculosis (TB) disease represents a greater hazard to a pregnant woman and her fetus than does its treatment. Treatment of pregnant wome...
    File Type:
    Filetype[PDF - 1.01 MB]
    File Type:
    Filetype[PDF - 1.01 MB]
  2. Corporate Authors:
    National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (U.S.), Division of Tuberculosis Elimination.
    Published Date:
    April 2012
    Series:
    TB elimination
    Description:
    CS229616_C.
    File Type:
    Filetype[PDF - 1.85 MB]
    File Type:
    Filetype[PDF - 1.85 MB]
  3. Corporate Authors:
    National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (U.S.), Division of Tuberculosis Elimination.
    Published Date:
    November 2008
    Series:
    TB elimination
    Description:
    "BCG, or bacille Calmette-Guerin, is a vaccine for tuberculosis (TB) disease. Many foreign-born persons have been BCG-vaccinated. BCG is used in many ...
    File Type:
    Filetype[PDF - 322.09 KB]
    File Type:
    Filetype[PDF - 322.09 KB]
  4. Corporate Authors:
    National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (U.S.), Division of Tuberculosis Elimination.
    Published Date:
    January 2013
    Series:
    TB elimination
    Description:
    Extensively drug resistant TB (XDR TB) is a rare type of multidrug-resistant tuberculosis (MDR TB) that is resistant to isoniazid and rifampin, plus a...
    File Type:
    Filetype[PDF - 421.42 KB]
    File Type:
    Filetype[PDF - 421.42 KB]
  5. Corporate Authors:
    National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (U.S.), Division of Tuberculosis Elimination.
    Published Date:
    March 2010
    Series:
    TB elimination
    File Type:
    Filetype[PDF - 1.89 MB]
    File Type:
    Filetype[PDF - 1.89 MB]